Normolose (Captopril)

Captopril blocks the angiotensin‑converting enzyme, preventing the conversion of angiotensin I into angiotensin II, a powerful vasoconstrictor. By reducing angiotensin II levels, it promotes vasodilation, decreases aldosterone secretion, and lowers sodium and water retention. These actions collectively lower systemic vascular resistance and blood pressure, and they also mitigate adverse cardiac remodeling after heart injury.

The appropriate dose of Normolose is determined by the prescribing physician, who considers the patient’s medical condition, age, kidney function, and response to therapy. Dosage may be started low and titrated upward as needed, and adjustments are made based on blood pressure readings and laboratory monitoring. Patients should follow the exact regimen provided by their healthcare provider.

Captopril is classified as a pregnancy category that requires caution; it should only be used when the potential benefit justifies the possible risk to the fetus. It can affect fetal renal development. During breastfeeding, captopril passes into breast milk in small amounts, and a decision to continue therapy should be made by the prescriber after weighing risks and benefits.

To request Normolose, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, and will ask for trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details—including any temperature controls—and assists with import documentation.

Captopril is one of the first‑generation ACE inhibitors and has a relatively short half‑life, requiring twice‑daily dosing in many cases. Compared with longer‑acting agents such as enalapril or lisinopril, captopril may achieve quicker onset of action but may also need more frequent administration. Choice of agent depends on patient-specific factors, tolerability, dosing convenience, and clinician preference.

Normolose tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and do not store in bathrooms or near heat sources. Do not use the medication after the expiry date printed on the label.

Normolose is taken orally, usually with or without food, as directed by the prescribing physician. The tablets should be swallowed whole with a full glass of water. Patients should avoid crushing or chewing the tablets unless specifically instructed, and they should adhere to the dosing schedule to maintain consistent blood levels of the medication.

The most serious adverse reactions to captopril include angioedema, which can cause swelling of the face, lips, tongue or airway and may be life‑threatening, as well as severe hyperkalemia that can lead to cardiac arrhythmias. Acute renal failure, especially in patients with pre‑existing kidney disease or dehydration, and severe neutropenia or liver injury are also critical concerns requiring immediate medical attention.

Normolose is contraindicated in patients with a known hypersensitivity to captopril or any other ACE inhibitor, a history of angioedema related to ACE‑inhibitor therapy, and in those with severe renal artery stenosis. It should also be avoided in patients with hereditary or idiopathic angioedema. Clinicians must review the patient’s medical history and current medications before initiating therapy to ensure safety.